Get the Stockscreener App
30.30
0.98%
-0.30
After Hours:
30.25
-0.05
-0.17%
Tectonic Therapeutic Inc stock is traded at $30.30, with a volume of 142.00K.
It is down -0.98% in the last 24 hours and up +57.81% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
See More
Previous Close:
$30.60
Open:
$30.36
24h Volume:
142.00K
Relative Volume:
2.33
Market Cap:
$450.88M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+44.84%
1M Performance:
+57.81%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$29.04
$30.94
1-Week Range:
$20.90
$31.66
52-Week Range:
$15.00
$31.66
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Tectonic Therapeutic Inc Stock (TECX) Latest News
Timothy A. Springer Acquires 50,000 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - Defense World
Tectonic Therapeutic director buys shares worth over $1.4 million - Investing.com
Tectonic Therapeutic director buys shares worth over $1.4 million By Investing.com - Investing.com UK
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Update - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Farallon Capital Management LLC Makes New $7.10 Million Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Farallon Capital Management LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tectonic Therapeutics stock earns continued Overweight rating on catalyst-packed 12 months ahead - Investing.com Canada
Tectonic Therapeutics stock earns continued Overweight rating on catalyst-packed 12 months ahead - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - MarketBeat
Tectonic reports positive Phase 1a results for heart treatment TX45 - Investing.com India
Tectonic reports positive Phase 1a results for heart treatment TX45 By Investing.com - Investing.com Australia
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 - Yahoo Finance
Tectonic reports positive Phase 1a results for heart treatment TX45 - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High at $19.88 - MarketBeat
Tectonic Therapeutic’s TX45 Shows Promise in Phase 1a Trial - TipRanks
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - GlobeNewswire
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Down to $18.65 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Down to $18.65 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 2.9% - MarketBeat
Atlas Venture Life Science Advisors LLC Purchases New Stake in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Up 52.6% in August - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $17.50 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 2.9% - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Up 50.4% in August - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Growth in Short Interest - Defense World
AVROBIO, Inc. announced that it has received $25.150002 million in funding from Atlas Venture L.P., SV Health Investors, LLC, Blackstone Life Sciences - Marketscreener.com
TECX Stock Earnings: Tectonic Therapeutic Misses EPS for Q2 2024 - InvestorPlace
Contrasting SpringWorks Therapeutics (NASDAQ:SWTX) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $16.25 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Tectonic stock wins bullish view at Wells Fargo (NASDAQ:TECX) - Seeking Alpha
Wells Fargo rates Tectonic Therapeutics shares Overweight, cites TX45's potential - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Research Coverage Started at Wells Fargo & Company - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Stock Quotes, Forecast and News Summary - Benzinga
Tectonic Therapeutic to Participate in September Investor Conferences - GlobeNewswire
Tectonic Therapeutic to Participate in September Investor Conferences - StockTitan
Tectonic Therapeutic to Participate in September Investor Conferences - Yahoo Finance
Q3 2024 Earnings Estimate for Tectonic Therapeutic Issued By Leerink Partnrs (NASDAQ:TECX) - MarketBeat
Leerink Partnrs Brokers Reduce Earnings Estimates for Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Strong Trading Volume - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 4.6% - MarketBeat
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - StockTitan
Head to Head Contrast: Tectonic Therapeutic (TECX) & Its Competitors - Defense World
Reviewing VectivBio (NASDAQ:VECT) & Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):